AbbVie
ABBV
ABBV
2,033 hedge funds and large institutions have $82.8B invested in AbbVie in 2019 Q1 according to their latest regulatory filings, with 128 funds opening new positions, 788 increasing their positions, 899 reducing their positions, and 130 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less capital invested
Capital invested by funds: $95.6B → $82.8B (-$12.8B)
20% less call options, than puts
Call options by funds: $996M | Put options by funds: $1.25B
59% less funds holding in top 10
Funds holding in top 10: 148 → 61 (-87)
Holders
2,033
Holding in Top 10
61
Calls
$996M
Puts
$1.25B
Top Buyers
| 1 | +$401M | |
| 2 | +$384M | |
| 3 | +$308M | |
| 4 |
Two Sigma Advisers
New York
|
+$304M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$239M |
Top Sellers
| 1 | -$2.18B | |
| 2 | -$400M | |
| 3 | -$309M | |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
-$189M |
| 5 |
Aristotle Capital Management
Los Angeles,
California
|
-$187M |